These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 12698311)

  • 1. Under-prescribing of cardiovascular therapies for diabetes in primary care.
    Bennett KE; Williams D; Feely J
    Eur J Clin Pharmacol; 2003 Apr; 58(12):835-41. PubMed ID: 12698311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Secondary prevention therapies for coronary heart disease in patients with type 2 diabetes: an audit.
    Sharma KK; Guptha S; Gupta R
    J Assoc Physicians India; 2012 Apr; 60():28-30. PubMed ID: 23029739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inequalities in prescribing of secondary preventative therapies for ischaemic heart disease in Ireland.
    Bennett KE; Williams D; Feely J
    Ir Med J; 2002 Jun; 95(6):169-72. PubMed ID: 12171263
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in prevalence of and prescribing for ischaemic heart disease in Ireland 1990-2002.
    Bennett K; Johnson H; Dack P; Shelley E; Feely J
    Ir J Med Sci; 2005; 174(3):4-8. PubMed ID: 16285330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of preventive cardiovascular pharmacotherapy after coronary artery bypass graft surgery.
    Barry AR; Koshman SL; Norris CM; Ross DB; Pearson GJ
    Pharmacotherapy; 2014 May; 34(5):464-72. PubMed ID: 24877186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of combinations of drugs on all cause mortality in patients with ischaemic heart disease: nested case-control analysis.
    Hippisley-Cox J; Coupland C
    BMJ; 2005 May; 330(7499):1059-63. PubMed ID: 15879390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in the Prescription of Glucose-Lowering Medications in Patients With Type 2 Diabetes Mellitus After a Cardiovascular Event: A Call to Action From the DATAFILE Study.
    Fadini GP; Frison V; Simioni N; Lapolla A; Gatti A; Bossi AC; Del Buono A; Fornengo P; Gottardo L; Laudato M; Perseghin G; Bonora E; Avogaro A
    J Am Heart Assoc; 2019 Jul; 8(14):e012244. PubMed ID: 31269877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prescription of statins: cost implications of evidence-based treatment applied to a health authority population.
    Bradshaw N; Walker R
    J Clin Pharm Ther; 1997; 22(5-6):379-89. PubMed ID: 19160723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence for an age and gender bias in the secondary prevention of ischaemic heart disease in primary care.
    Williams D; Bennett K; Feely J
    Br J Clin Pharmacol; 2003 Jun; 55(6):604-8. PubMed ID: 12814456
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coordinated Care to Optimize Cardiovascular Preventive Therapies in Type 2 Diabetes: A Randomized Clinical Trial.
    Pagidipati NJ; Nelson AJ; Kaltenbach LA; Leyva M; McGuire DK; Pop-Busui R; Cavender MA; Aroda VR; Magwire ML; Richardson CR; Lingvay I; Kirk JK; Al-Khalidi HR; Webb L; Gaynor T; Pak J; Senyucel C; Lopes RD; Green JB; Granger CB;
    JAMA; 2023 Apr; 329(15):1261-1270. PubMed ID: 36877177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regional variation in the prescribing for diabetes and use of secondary preventative therapies in Ireland.
    Usher C; Bennett K; Feely J
    Pharmacoepidemiol Drug Saf; 2005 Aug; 14(8):537-44. PubMed ID: 15818637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological treatment after acute myocardial infarction from 2001 to 2006: a survey in Italian primary care.
    Filippi A; D'Ambrosio G; Giustini SE; Pecchioli S; Mazzaglia G; Cricelli C
    J Cardiovasc Med (Hagerstown); 2009 Sep; 10(9):714-8. PubMed ID: 19465867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low use of statins and other coronary secondary prevention therapies in primary and secondary care in India.
    Sharma KK; Gupta R; Agrawal A; Roy S; Kasliwal A; Bana A; Tongia RK; Deedwania PC
    Vasc Health Risk Manag; 2009; 5():1007-14. PubMed ID: 19997570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancing prescribing of guideline-recommended medications for ischaemic heart diseases: a systematic review and meta-analysis of interventions targeted at healthcare professionals.
    Nguyen T; Nguyen HQ; Widyakusuma NN; Nguyen TH; Pham TT; Taxis K
    BMJ Open; 2018 Jan; 8(1):e018271. PubMed ID: 29326185
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Secondary prevention following coronary artery bypass grafting has improved but remains sub-optimal: the need for targeted follow-up.
    Turley AJ; Roberts AP; Morley R; Thornley AR; Owens WA; de Belder MA
    Interact Cardiovasc Thorac Surg; 2008 Apr; 7(2):231-4. PubMed ID: 18234766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adherence to drugs that prevent cardiovascular disease: meta-analysis on 376,162 patients.
    Naderi SH; Bestwick JP; Wald DS
    Am J Med; 2012 Sep; 125(9):882-7.e1. PubMed ID: 22748400
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimizing prevention and guideline-concordant care in Montenegro.
    Knežević B; Musić L; Batrićević G; Bošković A; Bulatović N; Nenezić A; Vujović J; Kalezić M
    Int J Cardiol; 2016 Aug; 217 Suppl():S32-6. PubMed ID: 27381861
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors associated with the use of evidence-based therapies after discharge among elderly patients with myocardial infarction.
    Austin PC; Tu JV; Ko DT; Alter DA
    CMAJ; 2008 Oct; 179(9):901-8. PubMed ID: 18936455
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Utilization of secondary prevention therapies in patients with nonobstructive coronary artery disease identified during cardiac catheterization: insights from the National Cardiovascular Data Registry Cath-PCI Registry.
    Maddox TM; Ho PM; Roe M; Dai D; Tsai TT; Rumsfeld JS
    Circ Cardiovasc Qual Outcomes; 2010 Nov; 3(6):632-41. PubMed ID: 20923997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of nitrates, calcium channel blockers and ACE inhibitors in primary care in the Northern Region: a pharmacoepidemiological study.
    Roberts SJ; Bateman DN
    Br J Clin Pharmacol; 1994 Dec; 38(6):489-97. PubMed ID: 7888286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.